Table 1.
The details of the six articles included in the current review and a meta-analysis
|
Study |
Publication date |
Follow-up |
Patient no. |
Surgical treatment groups |
Patient |
Recurrence rate |
Recurrence ( n) |
|---|---|---|---|---|---|---|---|
| (year) | (months) | ||||||
| Becker et al.[20] |
2008 |
63 |
384 |
Total cohort |
|
|
|
| |
|
|
78/384 |
wide resection |
|
2.00% |
1 |
| |
|
|
103/384 |
curettage (bone graft) |
|
49.00% |
56 |
| |
|
|
102/384 |
curettage + PMMA |
|
22.00% |
23 |
| |
|
|
74/384 |
curettage + PMMA + phenol |
|
27.00% |
20 |
| |
|
|
27/384 |
curettage + toxic(bone graft) |
|
15.00% |
4 |
| Errani et al.[11] |
2010 |
91 |
349 |
Total cohort |
|
|
|
| |
|
|
149/349 |
wide resection |
|
12.00% |
18 |
| |
|
|
136/349 |
Curettage + burr + phenol |
|
17.60% |
24 |
| |
|
|
64/349 |
Curettage + burr + phenol + PMMA |
|
12.50% |
8 |
| Kivioja et al.[15] |
2008 |
60 months |
294 |
Total cohort |
|
|
|
| |
|
|
92/294 |
wide resection |
|
12.00% |
11 |
| |
|
|
47/294 |
curettage |
|
51.00% |
24 |
| |
|
|
147/294 |
curettage + PMMA |
|
22.00% |
32 |
| Klenke et al.[2] |
2010 |
108 months |
118 |
Total cohort |
|
|
|
| |
|
|
UN |
wide resection |
|
5.00% |
unknown |
| |
|
|
22/118 |
curettage + burr |
|
32.00% |
7 |
| |
|
|
32/118 |
curettage + burr + phenol |
|
34.00% |
11 |
| |
|
|
41/118 |
curettage + burr + phenol + PMMA |
|
15.00% |
6 |
| Gaston et al.[12] |
2011 |
76.5 months |
330 |
Total cohort |
|
|
|
| |
|
|
246/330 |
curettage |
|
28.70% |
67 |
| |
|
|
84/330 |
curettage + PMMA |
|
14.30% |
12 |
| Jamshidi et al.[14] |
2008 |
74 months |
168 |
Total cohort |
|
|
|
| |
|
|
40/168 |
curettage + bone |
|
42.50% |
17 |
| |
|
|
40/168 |
curettage + cement |
|
30.00% |
12 |
| |
|
|
46/168 |
curettage + burr + bone |
|
21.70% |
10 |
| |
|
|
42/168 |
curettage + burr + cement |
|
16.70% |
7 |
| Harness et al. [22] |
2004 |
72 months |
31 |
|
|
|
|
| |
|
|
5/31 |
curettage + bone |
|
40.00% |
2 |
| |
|
|
26/31 |
curettage + PMMA |
|
42.00% |
11 |
| Ozalp et al.[23] |
2006 |
80 months |
8 |
Total cohort |
|
|
|
| |
|
|
6/8 |
curettage + bone |
|
50.00% |
3 |
| |
|
|
2/8 |
curettage + PMMA |
|
50.00% |
1 |
| Sheth et al.[24] |
1995 |
108 months |
16 |
Total cohort |
|
|
|
| |
|
|
9/16 |
curettage + bone |
|
33.00% |
3 |
| 7/16 | curettage + PMMA | 28.50% | 2 |